FDA Approves Novel Prostate Cancer “Vaccine”
The treatment, which works by turning the body’s immune system against invading cancer cells, is called Provenge and is manufactured by Seattle biotech firm Dendreon

Read more on Time Magazine

Tags: Approves, cancer, Novel, prostate, vaccine

Related posts

• U.S. to WellPoint: Stop dropping breast cancer patients
• Healthy Eating for Life to Prevent and Treat Cancer
• Breast Cancer Journal Engage Books
• WATCH: FDA Considers New Cancer Vaccine
• Poor ‘missing out on cancer care’

• Previous Entry: How to Fight Cancer & Win
• Next Entry: America’s First Therapeutic Cancer Vaccine